Cas:59490-33-4 2-[(4-chlorobenzoyl)amino]-3-phenylpropanoic acid manufacturer & supplier

We serve Chemical Name:2-[(4-chlorobenzoyl)amino]-3-phenylpropanoic acid CAS:59490-33-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-[(4-chlorobenzoyl)amino]-3-phenylpropanoic acid

Chemical Name:2-[(4-chlorobenzoyl)amino]-3-phenylpropanoic acid
CAS.NO:59490-33-4
Synonyms:N-(4-chloro-benzoylamino)-phenylalanine;N-(p-chlorobenzoyl)phenylalanine
Molecular Formula:C16H14ClNO3
Molecular Weight:303.74000
HS Code:2924299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:533ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:66.40000
Exact Mass:303.06600
LogP:3.15660

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N-(4-chloro-benzoylamino)-phenylalanine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(p-chlorobenzoyl)phenylalanine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(4-chloro-benzoylamino)-phenylalanine Use and application,N-(p-chlorobenzoyl)phenylalanine technical grade,usp/ep/jp grade.


Related News: But Vietnam then partly eased its ban, allowing flights from Hong Kong and Macau to continue, aviation authorities said. 2-[(4-chlorobenzoyl)amino]-3-phenylpropanoic acid manufacturer Active pharmaceutical ingredients directly impact disease. 2-[(4-chlorobenzoyl)amino]-3-phenylpropanoic acid supplier As a result, the Company��s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy. 2-[(4-chlorobenzoyl)amino]-3-phenylpropanoic acid vendor As a result, the Company��s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy. 2-[(4-chlorobenzoyl)amino]-3-phenylpropanoic acid factory These include: high-barrier generic drug substances and commonly used generic drug substances.